About SciBase
SciBase is a company based in Stockholm (Sweden) founded in 1998 by Stig Ollmar. It operates as a HealthTech and Direct-to-Consumer (D2C). SciBase has raised $22.3 million across 3 funding rounds from investors including SEB, CapMan and Van Herk Groep. The company has 32 employees as of December 31, 2024. SciBase offers products and services including Nevisense and Skin Barrier Assessment. SciBase operates in a competitive market with competitors including DermaSensor, MedLumics, DAMAE Medical, Vivosight and AI Medical Technology, among others.
- Headquarter Stockholm, Sweden
- Employees 32 as on 31 Dec, 2024
- Founders Stig Ollmar
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scibase Holding Ab
-
Annual Revenue
$2.69 M (USD)27.79as on Dec 31, 2024
-
Net Profit
-$5.54 M (USD)-9.97as on Dec 31, 2024
-
EBITDA
-$5.78 M (USD)-26.24as on Dec 31, 2024
-
Total Equity Funding
$22.3 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
SEB
& 6 more
-
Employee Count
32
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SciBase
SciBase is a publicly listed company on the OMXSTO with ticker symbol SCIB in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SciBase
SciBase offers a comprehensive portfolio of products and services, including Nevisense and Skin Barrier Assessment.
Nevisense is used for early skin cancer detection.
Skin barrier function is assessed using Nevisense platform.
People of SciBase
Unlock access to complete
Funding Insights of SciBase
SciBase has successfully raised a total of $22.3M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SciBase
SciBase has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include SEB, CapMan and Van Herk Groep.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life-Sciences & Offline focused VC firm funding companies in Netherlands
|
Locked | Locked | Locked | |
|
Venture capital firm backed by SEB group
|
Locked | Locked | Locked | |
|
A state-owned venture capital company focused on sustainable investments.
|
Locked | Locked | Locked |
Investor details for SciBase
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SciBase
Investment portfolio details for SciBase
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SciBase
Detailed financials for SciBase
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scibase Comparisons
Peer comparison for SciBase
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SciBase
SciBase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermaSensor, MedLumics, DAMAE Medical, Vivosight and AI Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| Locked | Locked | Locked |
Non-invasive 3D imaging devices for skin cancer diagnostics are developed.
|
|
| Locked | Locked | Locked |
Optical coherence tomography devices for dermatological diagnostics are provided.
|
|
| Locked | Locked | Locked |
AI-driven diagnostic tools for skin cancer detection are developed.
|
Detailed competitors of SciBase
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scibase
Complete news archive for SciBase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SciBase
SciBase was founded in 1998 and raised its 1st funding round 7 years after it was founded.
SciBase is headquartered in Stockholm, Sweden.
Emanuel von Kienlin is the current CEO of SciBase.
SciBase is a funded company, having raised a total of $22.3M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at SciBase is 32.
Annual revenue of SciBase is $2.69M as on Dec 31, 2024.
SciBase is focused on the development and commercialization of Nevisense, a point-of-care platform integrating AI and advanced EIS technology. The company operates in the healthcare sector, specifically targeting early detection and prevention of skin cancer and skin disorders. Solutions provided by SciBase empower healthcare professionals to improve diagnostic accuracy, facilitate disease monitoring, and enable early intervention. The platform is utilized in dermatology for melanoma detection and skin barrier assessments, contributing to proactive skin health management globally.
SciBase's top competitors include DermaSensor, MedLumics and AI Medical Technology.
SciBase offers Nevisense and Skin Barrier Assessment.
Yes, SciBase is publicly traded on OMXSTO under the ticker symbol SCIB.
SciBase has 7 investors. Key investors include SEB, CapMan, Van Herk Groep, ÖstVäst Advisory AB, and SEB Venture Capital.
The ticker symbol of SciBase is SCIB on OMXSTO.